Pharmaceutical Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from Publisher provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs market- How does the market relate to the overall economy, demography and other similar markets- What forces will shape the market going forward- The Pharmaceutical Drugs Market global report from Publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceutical drugs indicators comparison.
Scope
Markets Covered: 1) By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Subsegments Covered: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals; Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products; Anemia And Other Blood Disorder Drugs; Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal); Anti Diabetics drugs; Anti-Thyroid Drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism); Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs; Lung Cancer Drugs; Pancreatic Cancer Drugs; Breast Cancer Drugs; Prostate Cancer Drugs; Ovarian Cancer Drugs; Colorectal Cancer Drugs; Gastric Cancer Drugs; Kidney Cancer Drugs; Brain Tumor Drugs; Thyroid Cancer Drugs; Skin Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Blood Cancer Drugs; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma); Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations
Companies Mentioned: Novartis AG; Sanofi S.A.; Pfizer Inc.; Gilead Sciences, Inc.; Johnson & Johnson
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, pharmaceutical drugs indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Major companies in the pharmaceutical drug market include Novartis AG; Sanofi S.A.; Pfizer Inc.; Gilead Sciences, Inc. and Johnson & Johnson.
The global pharmaceutical drugs market is expected to grow from $975.04 billion in 2020 to $981.73 billion in 2021 at a compound annual growth rate (CAGR) of 0.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1280.42 billion in 2025 at a CAGR of 7%.
The pharmaceutical drug market consists of sales of goods and related services by entities (organizations, sole traders and partnerships) that produce and sell pharmaceutical drugs used to treat various diseases. This industry includes establishments that produce drugs such as cardiovascular drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs and other drugs used to treat cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others. The pharmaceutical drug market is segmented into cardiovascular drugs; dermatology drugs; gastrointestinal drugs; genito-urinary drugs; hematology drugs; anti-infective drugs; metabolic disorders drugs; musculoskeletal disorders drugs; central nervous system drugs; oncology drugs; ophthalmology drugs; and respiratory diseases drugs.
North America was the largest region in the global pharmaceutical drugs market, accounting for 44% of the market in 2020. Asia Pacific was the second largest region accounting for 27% of the global pharmaceutical drugs market. Africa was the smallest region in the global pharmaceutical drugs market.
Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. For example, in 2020 FDA has switched three prescription drugs to OTC including Voltaren for arthritis pain, olopatadine hydrochloride 0.1% and 0.2%(Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes due to pollen, ragweed and grass.
Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research and development of new products. For instance, the US interest rates are expected to rise up to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the pharmaceuticals market growth.
The rise in sedentary jobs, busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. China and India together had about 193.4 million diabetic patients in 2019 and India is expected to have about 101 million diabetic patients by 2030, thereby increasing the need for biologics drugs for diabetic patients. These factors are expected to increase the patient pool globally, thereby driving the pharmaceutical drugs market during the forecast period.
Table of Contents
1. Executive Summary
2. Report Structure
3. Pharmaceutical Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations
4. Pharmaceutical Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products
5. Pharmaceutical Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers
6. Pharmaceutical Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth
7. Pharmaceutical Drugs Market Trends And Strategies
8. Impact Of COVID-19 On Pharmaceutical Drugs
9. Pharmaceutical Drugs Market Size And Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers Of The Market
9.2.2. Restraints On The Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers Of The Market
9.3.2. Restraints On The Market
10. Pharmaceutical Drugs Market Regional Analysis
10.1. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
10.2. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
10.3. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Region
11. Pharmaceutical Drugs Market Segmentation
11.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Cardiovascular Drugs
Dermatology Drugs
Gastrointestinal Drugs
Genito-Urinary Drugs
Hematology Drugs
Anti-Infective Drugs
Metabolic Disorders Drugs
Musculoskeletal Disorders Drugs
Central Nervous System Drugs
Oncology Drugs
Ophthalmology Drugs
Respiratory Diseases Drugs
11.2. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others
11.3. Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Oral
Parenteral
Others
11.4. Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Branded Drugs
Generic Drugs
11.5. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs
12. Pharmaceutical Drugs Market Segments
12.1. Global Cardiovascular Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.2. Global Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.3. Global Gastrointestinal Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.4. Global Genito-Urinary Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.5. Global Hematology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.6. Global Anti-Infective Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.7. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.8. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.9. Global Central Nervous System Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.10. Global Oncology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.11. Global Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
12.12. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13. Pharmaceutical Drugs Market Metrics
13.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, 2015-2025, Global
13.2. Per Capita Average Pharmaceutical Drugs Market Expenditure, 2015-2025, Global
14. Asia-Pacific Pharmaceutical Drugs Market
14.1. Asia-Pacific Pharmaceutical Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Asia-Pacific, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
14.3. Asia-Pacific, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
14.4. Asia-Pacific, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Asia-Pacific, Pharmaceutical Drugs Market Metrics
14.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, Asia-Pacific Countries
14.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, Asia-Pacific Countries
14.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, Asia-Pacific Countries
14.6. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
14.7.1. China Pharmaceutical Drugs Market
14.7.1.1. China Pharmaceutical Drugs Market Overview
14.7.1.2. China Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Australia Pharmaceutical Drugs Market
14.7.2.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Hong Kong Pharmaceutical Drugs Market
14.7.3.1. Hong Kong Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. India Pharmaceutical Drugs Market
14.7.4.1. India Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. Indonesia Pharmaceutical Drugs Market
14.7.5.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Japan Pharmaceutical Drugs Market
14.7.6.1. Japan Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Malaysia Pharmaceutical Drugs Market
14.7.7.1. Malaysia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. New Zealand Pharmaceutical Drugs Market
14.7.8.1. New Zealand Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Philippines Pharmaceutical Drugs Market
14.7.9.1. Philippines Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Singapore Pharmaceutical Drugs Market
14.7.10.1. Singapore Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. South Korea Pharmaceutical Drugs Market
14.7.11.1. South Korea Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Thailand Pharmaceutical Drugs Market
14.7.12.1. Thailand Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Vietnam Pharmaceutical Drugs Market
14.7.13.1. Vietnam Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15. Western Europe Pharmaceutical Drugs Market
15.1. Western Europe Pharmaceutical Drugs Market Overview
15.2. Western Europe, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
15.3. Western Europe, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
15.4. Western Europe, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. Western Europe, Pharmaceutical Drugs Market Metrics
15.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, Western Europe Countries
15.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, Western Europe Countries
15.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, Western Europe Countries
15.6. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Western Europe Pharmaceutical Drugs Market: Country Analysis
15.7.1. Austria Pharmaceutical Drugs Market
15.7.1.1. Austria Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Belgium Pharmaceutical Drugs Market
15.7.2.1. Belgium Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Denmark Pharmaceutical Drugs Market
15.7.3.1. Denmark Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Finland Pharmaceutical Drugs Market
15.7.4.1. Finland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.5. France Pharmaceutical Drugs Market
15.7.5.1. France Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.6. Germany Pharmaceutical Drugs Market
15.7.6.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.7. Ireland Pharmaceutical Drugs Market
15.7.7.1. Ireland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.8. Italy Pharmaceutical Drugs Market
15.7.8.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.9. Netherlands Pharmaceutical Drugs Market
15.7.9.1. Netherlands Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.10. Norway Pharmaceutical Drugs Market
15.7.10.1. Norway Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.11. Portugal Pharmaceutical Drugs Market
15.7.11.1. Portugal Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.12. Spain Pharmaceutical Drugs Market
15.7.12.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.13. Sweden Pharmaceutical Drugs Market
15.7.13.1. Sweden Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.14. Switzerland Pharmaceutical Drugs Market
15.7.14.1. Switzerland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.15. UK Pharmaceutical Drugs Market
15.7.15.1. UK Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16. Eastern Europe Pharmaceutical Drugs Market
16.1. Eastern Europe Pharmaceutical Drugs Market Overview
16.2. Eastern Europe, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
16.3. Eastern Europe, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
16.4. Eastern Europe, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. Eastern Europe, Pharmaceutical Drugs Market Metrics
16.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, Eastern Europe Countries
16.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, Eastern Europe Countries
16.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, Eastern Europe Countries
16.6. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. Eastern Europe Pharmaceutical Drugs Market: Country Analysis
16.7.1. Czech Republic Pharmaceutical Drugs Market,
16.7.1.1. Czech Republic Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Poland Pharmaceutical Drugs Market
16.7.2.1. Poland Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. Romania Pharmaceutical Drugs Market
16.7.3.1. Romania Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.4. Russia Pharmaceutical Drugs Market
16.7.4.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17. North America Pharmaceutical Drugs Market
17.1. North America Pharmaceutical Drugs Market Overview
17.2. North America, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
17.3. North America, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
17.4. North America, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. North America, Pharmaceutical Drugs Market Metrics
17.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, North America Countries
17.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, North America Countries
17.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, North America Countries
17.6. North America Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. North America Pharmaceutical Drugs Market: Country Analysis
17.7.1. Canada Pharmaceutical Drugs Market
17.7.1.1. Canada Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Mexico Pharmaceutical Drugs Market
17.7.2.1. Mexico Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. USA Pharmaceutical Drugs Market
17.7.3.1. USA Pharmaceutical Drugs Market Overview
17.7.3.2. USA Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18. South America Pharmaceutical Drugs Market
18.1. South America Pharmaceutical Drugs Market Overview
18.2. South America, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
18.3. South America, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
18.4. South America, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. South America, Pharmaceutical Drugs Market Metrics
18.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, South America Countries
18.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, South America Countries
18.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, South America Countries
18.6. South America Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. South America Pharmaceutical Drugs Market: Country Analysis
18.7.1. Argentina Pharmaceutical Drugs Market
18.7.1.1. Argentina Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Brazil Pharmaceutical Drugs Market
18.7.2.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Chile Pharmaceutical Drugs Market
18.7.3.1. Chile Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. Colombia Pharmaceutical Drugs Market
18.7.4.1. Colombia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.5. Peru Pharmaceutical Drugs Market
18.7.5.1. Peru Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.6. Venezuela Pharmaceutical Drugs Market
18.7.6.1. Venezuela Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19. Middle East Pharmaceutical Drugs Market
19.1. Middle East Pharmaceutical Drugs Market Overview
19.2. Middle East, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
19.3. Middle East, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
19.4. Middle East, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
19.5. Middle East, Pharmaceutical Drugs Market Metrics
19.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, Middle East Countries
19.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, Middle East Countries
19.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, Middle East Countries
19.6. Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Middle East Pharmaceutical Drugs Market: Country Analysis
19.7.1. Saudi Arabia Pharmaceutical Drugs Market
19.7.1.1. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Israel Pharmaceutical Drugs Market
19.7.2.1. Israel Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. Turkey Pharmaceutical Drugs Market
19.7.3.1. Turkey Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.4. UAE Pharmaceutical Drugs Market
19.7.4.1. UAE Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20. Africa Pharmaceutical Drugs Market
20.1. Africa Pharmaceutical Drugs Market Overview
20.2. Africa, Pharmaceutical Drugs Market, 2020, By Country, Value ($ Billion)
20.3. Africa, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
20.4. Africa, Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
20.5. Africa, Pharmaceutical Drugs Market Metrics
20.5.1. Per Capita Average Pharmaceutical Drugs Expenditure, 2015-2025, Africa Countries
20.5.2. Number of Enterprises, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Enterprises, 2020, Africa Countries
20.5.3. Number of Employees, Pharmaceutical Drugs Market, Pharmaceutical Drugs Market/Number of Employees, 2020, Africa Countries
20.6. Africa Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7. Africa Pharmaceutical Drugs Market: Country Analysis
20.7.1. Egypt Pharmaceutical Drugs Market
20.7.1.1. Egypt Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7.2. Nigeria Pharmaceutical Drugs Market
20.7.2.1. Nigeria Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
20.7.3. South Africa Pharmaceutical Drugs Market
20.7.3.1. South Africa Pharmaceutical Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
21. Pharmaceutical Drugs Market Competitive Landscape
21.1. Competitive Market Overview
21.2. Market Shares
21.3. Company Profiles
21.3.1. Novartis AG
21.3.1.1. Company Overview
21.3.1.2. Products And Services
21.3.1.3. Strategy
21.3.1.4. Financial Performance
21.3.2. Sanofi S.A.
21.3.2.1. Company Overview
21.3.2.2. Products And Services
21.3.2.3. Strategy
21.3.2.4. Financial Performance
21.3.3. Pfizer Inc.
21.3.3.1. Company Overview
21.3.3.2. Products And Services
21.3.3.3. Strategy
21.3.3.4. Financial Performance
21.3.4. Gilead Sciences, Inc.
21.3.4.1. Company Overview
21.3.4.2. Products And Services
21.3.4.3. Strategy
21.3.4.4. Financial Performance
21.3.5. Johnson & Johnson
21.3.5.1. Company Overview
21.3.5.2. Products And Services
21.3.5.3. Strategy
21.3.5.4. Financial Performance
22. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
23. Market Background: Pharmaceuticals Market
23.1. Pharmaceuticals Market Characteristics
23.2. Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
23.3. Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)
23.4. Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
23.5. Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
24. Recommendations
24.1. Global Pharmaceutical Drugs Market In 2025- Growth Countries
24.2. Global Pharmaceutical Drugs Market In 2025- Growth Segments
24.3. Global Pharmaceutical Drugs Market In 2025- Growth Strategies
25. Appendix
25.1. NAICS Definitions Of Industry Covered In This Report
25.2. Abbreviations
25.3. Currencies
25.4. Research Inquiries
25.5. The Business Research Company
26. Copyright And Disclaimer
Novartis AG
Sanofi S.A.
Pfizer Inc.
Gilead Sciences, Inc.
Johnson & Johnson